An Apoptosis-Inducing Peptidic Heptad That Efficiently Clusters Death Receptor 5

Angew Chem Int Ed Engl. 2016 Apr 11;55(16):5085-9. doi: 10.1002/anie.201511894. Epub 2016 Mar 15.

Abstract

Multivalent ligands of death receptors hold particular promise as tumor cell-specific therapeutic agents because they induce an apoptotic cascade in cancerous cells. Herein, we present a modular approach to generate death receptor 5 (DR5) binding constructs comprising multiple copies of DR5 targeting peptide (DR5TP) covalently bound to biomolecular scaffolds of peptidic nature. This strategy allows for efficient oligomerization of synthetic DR5TP-derived peptides in different spatial orientations using a set of enzyme-promoted conjugations or recombinant production. Heptameric constructs based on a short (60-75 residues) scaffold of a C-terminal oligomerization domain of human C4b binding protein showed remarkable proapoptotic activity (EC50=3 nm) when DR5TP was ligated to its carboxy terminus. Our data support the notion that inter-ligand distance, relative spatial orientation and copy number of receptor-binding modules are key prerequisites for receptor activation and cell killing.

Keywords: C4BP; TRAIL mimicking peptide; apoptosis; death receptor 5; oligomerization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis*
  • Humans
  • Peptides / metabolism*
  • Receptors, TNF-Related Apoptosis-Inducing Ligand / metabolism*

Substances

  • Peptides
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • TNFRSF10B protein, human